These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 20840742)

  • 1. A possible role for miRNA silencing in disease phenotype variation in Swedish transthyretin V30M carriers.
    Olsson M; Norgren N; Obayashi K; Plante-Bordeneuve V; Suhr OB; Cederquist K; Jonasson J
    BMC Med Genet; 2010 Sep; 11():130. PubMed ID: 20840742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allele specific expression of the transthyretin gene in swedish patients with hereditary transthyretin amyloidosis (ATTR V30M) is similar between the two alleles.
    Norgren N; Hellman U; Ericzon BG; Olsson M; Suhr OB
    PLoS One; 2012; 7(11):e49981. PubMed ID: 23185504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum transthyretin levels in Swedish TTR V30M carriers.
    Buxbaum J; Anan I; Suhr O
    Amyloid; 2010 Jun; 17(2):83-5. PubMed ID: 20462367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haplotypes and DNA sequence variation within and surrounding the transthyretin gene: genotype-phenotype correlations in familial amyloid polyneuropathy (V30M) in Portugal and Sweden.
    Soares ML; Coelho T; Sousa A; Holmgren G; Saraiva MJ; Kastner DL; Buxbaum JN
    Eur J Hum Genet; 2004 Mar; 12(3):225-37. PubMed ID: 14673473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TTR familial amyloid polyneuropathy: does a mitochondrial polymorphism entirely explain the parent-of-origin difference in penetrance?
    Bonaïti B; Olsson M; Hellman U; Suhr O; Bonaïti-Pellié C; Planté-Bordeneuve V
    Eur J Hum Genet; 2010 Aug; 18(8):948-52. PubMed ID: 20234390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of penetrance in familial amyloid polyneuropathy, ATTR Val30Met, in the Swedish population.
    Hellman U; Alarcon F; Lundgren HE; Suhr OB; Bonaiti-Pellié C; Planté-Bordeneuve V
    Amyloid; 2008 Sep; 15(3):181-6. PubMed ID: 18925456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial haplogroup is associated with the phenotype of familial amyloidosis with polyneuropathy in Swedish and French patients.
    Olsson M; Hellman U; Planté-Bordeneuve V; Jonasson J; Lång K; Suhr OB
    Clin Genet; 2009 Feb; 75(2):163-8. PubMed ID: 19018796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement C1Q polymorphisms modulate onset in familial amyloidotic polyneuropathy TTR Val30Met.
    Dardiotis E; Koutsou P; Zamba-Papanicolaou E; Vonta I; Hadjivassiliou M; Hadjigeorgiou G; Cariolou M; Christodoulou K; Kyriakides T
    J Neurol Sci; 2009 Sep; 284(1-2):158-62. PubMed ID: 19493541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Family dynamics in transthyretin-related familial amyloid polyneuropathy Val30Met: Does genetic risk affect family functioning?
    Lopes A; Rodrigues C; Fonseca I; Sousa A; Branco M; Coelho T; Sequeiros J; Freitas P
    Clin Genet; 2018 Nov; 94(5):401-408. PubMed ID: 30019395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling familial amyloidotic polyneuropathy (Transthyretin V30M) in Drosophila melanogaster.
    Berg I; Thor S; Hammarström P
    Neurodegener Dis; 2009; 6(3):127-38. PubMed ID: 19372706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beyond Val30Met transthyretin (TTR): variants associated with age-at-onset in hereditary ATTRv amyloidosis.
    Alves-Ferreira M; Azevedo A; Coelho T; Santos D; Sequeiros J; Alonso I; Sousa A; Lemos C
    Amyloid; 2021 Jun; 28(2):100-106. PubMed ID: 33461327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral Blood Cell Gene Expression Diagnostic for Identifying Symptomatic Transthyretin Amyloidosis Patients: Male and Female Specific Signatures.
    Kurian SM; Novais M; Whisenant T; Gelbart T; Buxbaum JN; Kelly JW; Coelho T; Salomon DR
    Theranostics; 2016; 6(11):1792-809. PubMed ID: 27570551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility and modifier genes in Portuguese transthyretin V30M amyloid polyneuropathy: complexity in a single-gene disease.
    Soares ML; Coelho T; Sousa A; Batalov S; Conceição I; Sales-Luís ML; Ritchie MD; Williams SM; Nievergelt CM; Schork NJ; Saraiva MJ; Buxbaum JN
    Hum Mol Genet; 2005 Feb; 14(4):543-53. PubMed ID: 15649951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Trans-acting Factor May Modify Age at Onset in Familial Amyloid Polyneuropathy ATTRV30M in Portugal.
    Alves-Ferreira M; Coelho T; Santos D; Sequeiros J; Alonso I; Sousa A; Lemos C
    Mol Neurobiol; 2018 May; 55(5):3676-3683. PubMed ID: 28527106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of N-glycosylated transthyretin in plasma of V30M carriers in familial amyloidotic polyneuropathy: an escape from ERAD.
    Teixeira AC; Saraiva MJ
    J Cell Mol Med; 2013 Mar; 17(3):429-35. PubMed ID: 23387326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of antibodies against amyloidogenic transthyretin (ATTR) on phenotypes of patients with familial amyloidotic polyneuropathy (FAP) ATTR Valine30Methionine.
    Obayashi K; Tasaki M; Jono H; Ueda M; Shinriki S; Misumi Y; Yamashita T; Oshima T; Nakamura T; Ikemizu S; Anan I; Suhr O; Ando Y
    Clin Chim Acta; 2013 Apr; 419():127-31. PubMed ID: 23462670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of albumin on transthyretin and amyloidogenic transthyretin Val30Met disposition and tissue deposition in familial amyloidotic polyneuropathy.
    Taguchi K; Jono H; Kugimiya-Taguchi T; Nagao S; Su Y; Yamasaki K; Mizuguchi M; Maruyama T; Ando Y; Otagiri M
    Life Sci; 2013 Dec; 93(25-26):1017-22. PubMed ID: 24211615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and clinical characteristics of hereditary transthyretin amyloidosis in endemic and non-endemic areas: experience from a single-referral center in Japan.
    Yamashita T; Ueda M; Misumi Y; Masuda T; Nomura T; Tasaki M; Takamatsu K; Sasada K; Obayashi K; Matsui H; Ando Y
    J Neurol; 2018 Jan; 265(1):134-140. PubMed ID: 29177547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New data on the genetic profile and penetrance of hereditary Val30Met transthyretin amyloidosis in Sweden.
    Gorram F; Olsson M; Alarcon F; Nuel G; Anan I; Planté-Bordeneuve V
    Amyloid; 2021 Jun; 28(2):84-90. PubMed ID: 33146042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcome of patients with hereditary transthyretin V30M amyloidosis with polyneuropathy after liver transplantation.
    Okumura K; Yamashita T; Masuda T; Misumi Y; Ueda A; Ueda M; Obayashi K; Jono H; Yamashita S; Inomata Y; Ando Y
    Amyloid; 2016; 23(1):39-45. PubMed ID: 26763274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.